Search

Search Results

• PO:17:259 | Anifrolumab: a new management of SLE Giorgia Montozzi¹, Chiara Cocco¹, Ramona Santangeli¹, Lucia Gamba¹, Paola Fioretti¹, Letizia Curina¹, Chiara Guidoni¹, Edoardo Cipolletta³, Gianluca Moroncini² | ¹Scuola di Specializzazione in Medicina Interna, Università Politecnica delle Marche Ancona, Italy; ²Department of Clinical and Molecular Sciences, Università Politecnica delle Marche Ancona, Italy; ³Rheumatology Unit, Department of Clinical and Molecular Sciences , Università Politecnica delle Marche Ancona, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2336

  143

• Opportunities in Rheumatology

  S. Stisi

  331-333

  https://doi.org/10.4081/reumatismo.2001.331

  976

  Downloads: 689

• PO:06:092 | Early achievement of remission confers better outcomes than low disease activity in both seropositive and seronegative patients with new-onset rheumatoid arthritis Clelia Zampaglione^1|2, Ludovico De Stefano^1|2, Federica Sabatelli^1|2, Alessio D'Isanto^1|2, Blerina Xoxi^1|2, Antonio Manzo^1|2, Carlomaurizio Montecucco^1|2, Serena Bugatti^1|2. | ¹Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; ²Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2017

  219

• CO:07:4 | Clinical and psychosocial domains in fibromyalgia: a multidimensional questionnaire approach for personalized management. Results from an Italian monocentric study Eleonora Pedretti¹, Francesca Regola¹, Giulia Fontana^1|2, Giulia Voltarel^1|2, Michela Riolfo^1|2, Anna Scalvini¹, Ilaria Cavazzana^1|2, Franco Franceschini^1|2, Roberto Gorla¹. | ¹Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili of Brescia; ²Department of Clinical and Experimental Sciences, University of Brescia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1979

  274

• PO:38:281 | Therapeutic exercise in temporomandibular disorders: a scoping review of the literature Federico Amateis¹, Gabriele Aimini¹, Paolo Mastromarchi¹, Lorenzo Lo Russo¹, Marco Chiodini¹, Roberta Giova Bazzacchi¹, Noemi Corbetta¹, Stefano Salvioli¹.   | <i> ¹Department of Neurosciences, Rehabilitation, Opthalmology, Genetics, Maternal and Child Health, University of Genoa Italy; ³Scuola Universitaria per la Svizzera Italiana, DEASS Manno Switzerland; ⁶Department of Maxillo-Facial Surgery, Santi Paolo e Carlo Hospital, University of Milan Italy; ⁷Department of Neurosciences, Rehabilitation, Opthalmology , Genetics, Maternal and Child Health, University of Genoa Italy; ⁸Department of Neurosciences, Rehabilitation, Opthalmology , Genetics, Maternal and Child Health, University of Genoa Italy. </i>

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2225

  236

• S13:6 | Investigating the intricate interplay between pulmonary functionality and advanced microangiopathy in very early diagnosis of systemic sclerosis Eugenio Capparelli¹, Eleonora Zaccara¹, Daniela Bompane¹, Elisabetta Ricchiuto², Giorgio Bonardi², Laura Castelnovo¹, Antonio Tamburello¹, Antonino Mazzone³, Paola Faggioli¹. | ¹Rheumatology Unit; ²Pneumology Unit; ³Internal Medicine Unit, ASST Ovest Milanese, Legnano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2104

  183

• PO:24:064 | IPF vs CTD-ILD: Survival and Lung Function from an Italian Real-World Cohort Marco Fornaro¹, Donato Lacedonia², Lorenzo Cavagna³, Paolo Airò⁴, Marco Sebastiani⁵, Gianluca Sambataro⁶, Fabio Cacciapaglia⁷, Angelica Napoletano¹, Cosimo De Pace², Pasquale Tondo², Giulia Scioscia², Eleonora Pedretti⁴, Maria Grazia Lazzaroni⁴, Carlo Vancheri⁸, Andreina Manfredi⁹, Lorenzo Binchessi³, Rocco Capece³, Michele De Ceglie¹⁰, Massimo Giotta¹¹, Florenzo Iannone¹ | ¹Unit of Rheumatology, Department of Precision and Regenerative Medicine - Area Jonica DiMePRe-J, University of Bari, Bari, Italy; ²Department of Medical and Surgical Sciences, University of Foggia Foggia, Italy; ³Department of Internal Medicine and Therapeutics, University of Pavia, Division of Rheumatology, Fondazione IRCCS, Pavia, Italy; ⁴Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili Brescia, Italy; ⁵Rheumatology Unit, AUSL Piacenza, Department of Medicine and Surgery, University of Parma, Parma, Italy; ⁶Department of Medicine and Surgery, University of Enna Kore, Enna, Italy; ⁷Rheumatology Service, F. Miulli Hospital and Department of Medicine and Surgery, LUM University, Casamassima, Italy; ⁸Department of Clinical and Experimental Medicine, Regional Referral Center for Rare Lung Diseases, Catania, Italy; ⁹Rheumatology Unit, IRCCS Santa Maria Nuova Reggio Emilia, University of Modena, Modena, Italy; ¹⁰DIM, Interdisciplinary Department of Medicine, Section of Diagnostic Imaging, University of Bari, Bari, Italy; ¹¹Health Prevention Department, Local Health Authority of Brindisi, Brindisi, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2351

  184

• PO:03:033 | Low Uveitis Rates in Patients with Axial Spondyloarthritis or Psoriatic Arthritis Treated with Bimekizumab: Long-Term Results from Phase 2b/3 Trials Irene E Van Der Horst-Bruinsma¹, Matthew A Brown², Floris A Van Gaalen³, Nigil Haroon⁴, Lianne S Gensler⁵, Alexander Marten⁶, Myriam Manente⁷, George Stojan⁸, Thomas Vaux⁹, Katy White⁹, Atul Deodhar¹⁰, Nicola Boffini¹¹, Martin Rudwaleit¹² | ¹Department of Rheumatology, Radboud University Medical Centre Nijmegen, The Netherlands; ²Genomics England London, United Kingdom; ³Department of Rheumatology, Leiden University Medical Center Leiden, The Netherlands; ⁴Department of Medicine/Rheumatology, University Health Network, Schroeder Arthritis Institute, University of Toronto Toronto, Canada; ⁵Department of Medicine/Rheumatology, University of California San Francisco, USA; ⁶UCB Monheim am Rhein Germany; ⁷UCB Braine-lAlleud, Belgium; ⁸UCB Atlanta, USA; ⁹UCB Slough, United Kingdom; ¹⁰Division of Arthritis and Rheumatic Diseases, Oregon Health and Science University Portland, USA; ¹¹IRCCS Ospedale San Raffaele Milan, Italy; ¹²Klinikum Bielefeld, University of Bielefeld, Bielefeld, Germany

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2289

  56

• PO:20:006 | Efficacy of denosumab in glucocorticoid-induced osteoporosis patients with prior exposure to intravenous aminobisphosphonates Kiren Khalid¹, Alessandro Giollo¹, Mariangela Salvato¹, Francesca Frizzera¹, Lorenzo Di Luozzo¹, Bernd Raffeiner², Andrea Doria¹ | ¹Rheumatology Unit, Department of Medicine - DIMED, University of Padova, Padova, Italy; ²Department of Rheumatology, Bolzano Central Hospital, Bolzano, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2341

  71